JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $28,982 | +55.2% | 15,666 | -6.9% | 0.00% | – |
Q4 2022 | $18,672 | -52.1% | 16,822 | +1.1% | 0.00% | – |
Q3 2022 | $39,000 | -29.1% | 16,632 | -7.7% | 0.00% | – |
Q2 2022 | $55,000 | -42.7% | 18,019 | +27.8% | 0.00% | – |
Q1 2022 | $96,000 | -35.6% | 14,095 | -20.8% | 0.00% | – |
Q4 2021 | $149,000 | +12.9% | 17,796 | 0.0% | 0.00% | – |
Q3 2021 | $132,000 | -57.3% | 17,796 | -60.9% | 0.00% | – |
Q2 2021 | $309,000 | +15.3% | 45,491 | +74.0% | 0.00% | – |
Q1 2021 | $268,000 | +46.4% | 26,139 | 0.0% | 0.00% | – |
Q4 2020 | $183,000 | -14.1% | 26,139 | 0.0% | 0.00% | – |
Q3 2020 | $213,000 | +25.3% | 26,139 | +6.3% | 0.00% | – |
Q2 2020 | $170,000 | +45.3% | 24,591 | 0.0% | 0.00% | – |
Q1 2020 | $117,000 | -45.6% | 24,591 | +0.1% | 0.00% | – |
Q4 2019 | $215,000 | +165.4% | 24,577 | +0.6% | 0.00% | – |
Q3 2019 | $81,000 | -33.1% | 24,425 | 0.0% | 0.00% | – |
Q2 2019 | $121,000 | -19.9% | 24,425 | 0.0% | 0.00% | – |
Q1 2019 | $151,000 | +42.5% | 24,425 | -22.0% | 0.00% | – |
Q4 2018 | $106,000 | -32.5% | 31,319 | +29.8% | 0.00% | – |
Q3 2018 | $157,000 | -15.1% | 24,129 | 0.0% | 0.00% | – |
Q2 2018 | $185,000 | -63.0% | 24,129 | +7.8% | 0.00% | -100.0% |
Q1 2018 | $500,000 | +70.6% | 22,374 | -2.7% | 0.00% | 0.0% |
Q4 2017 | $293,000 | -19.9% | 23,000 | -2.1% | 0.00% | 0.0% |
Q3 2017 | $366,000 | +120.5% | 23,500 | +99.2% | 0.00% | – |
Q2 2017 | $166,000 | -40.5% | 11,800 | -7.1% | 0.00% | -100.0% |
Q1 2017 | $279,000 | – | 12,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|